Sunčica Kapor

570 total citations
24 papers, 264 citations indexed

About

Sunčica Kapor is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Sunčica Kapor has authored 24 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Sunčica Kapor's work include Immune cells in cancer (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Acute Myeloid Leukemia Research (5 papers). Sunčica Kapor is often cited by papers focused on Immune cells in cancer (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Acute Myeloid Leukemia Research (5 papers). Sunčica Kapor collaborates with scholars based in Serbia, Chile and United States. Sunčica Kapor's co-authors include Juan F. Santibáñez, Vladan P. Čokić, Slavko Mojsilović, Branka Filipović, Olivera Mitrović Ajtić, Elisabeth Ersvær, Helen Α. Papadaki, Mikaël Roussel, Astrid Olsnes Kittang and Maria Velegraki and has published in prestigious journals such as International Journal of Molecular Sciences, FEBS Journal and Oxidative Medicine and Cellular Longevity.

In The Last Decade

Sunčica Kapor

22 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sunčica Kapor Serbia 9 94 79 56 45 43 24 264
Jin-Ah Baek South Korea 9 147 1.6× 94 1.2× 26 0.5× 54 1.2× 36 0.8× 14 325
Iwona Janicka Poland 9 122 1.3× 117 1.5× 30 0.5× 38 0.8× 64 1.5× 18 357
Nicole Busch Germany 5 114 1.2× 128 1.6× 46 0.8× 20 0.4× 20 0.5× 6 459
Saskia N. I. von Ungern‐Sternberg Germany 9 115 1.2× 164 2.1× 55 1.0× 71 1.6× 14 0.3× 10 369
Megan M. Herr United States 9 32 0.3× 57 0.7× 33 0.6× 96 2.1× 42 1.0× 35 256
Gaël Poitevin France 10 50 0.5× 118 1.5× 27 0.5× 37 0.8× 27 0.6× 18 341
Boyan Wang China 8 40 0.4× 182 2.3× 40 0.7× 51 1.1× 51 1.2× 14 356
Sanne L. Maas Germany 7 114 1.2× 64 0.8× 16 0.3× 25 0.6× 12 0.3× 22 220
Zhongxun Yu China 11 80 0.9× 193 2.4× 16 0.3× 123 2.7× 21 0.5× 32 448
Kelley R. Jordan United States 10 101 1.1× 34 0.4× 64 1.1× 20 0.4× 54 1.3× 14 232

Countries citing papers authored by Sunčica Kapor

Since Specialization
Citations

This map shows the geographic impact of Sunčica Kapor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunčica Kapor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunčica Kapor more than expected).

Fields of papers citing papers by Sunčica Kapor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sunčica Kapor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunčica Kapor. The network helps show where Sunčica Kapor may publish in the future.

Co-authorship network of co-authors of Sunčica Kapor

This figure shows the co-authorship network connecting the top 25 collaborators of Sunčica Kapor. A scholar is included among the top collaborators of Sunčica Kapor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sunčica Kapor. Sunčica Kapor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kapor, Sunčica, et al.. (2024). Myeloid-derived suppressor cells: Implication in myeloid malignancies and immunotherapy. Acta Histochemica. 126(5-7). 152183–152183. 5 indexed citations
2.
Kapor, Sunčica, et al.. (2024). Mesenchymal stromal cells in myeloid malignancies: Immunotherapeutic opportunities. Heliyon. 10(3). e25081–e25081.
3.
Filipović, Branka, Dragana Mijač, Snežana Lukić, et al.. (2023). Molecular Aspects of MAFLD—New Insights on Pathogenesis and Treatment. Current Issues in Molecular Biology. 45(11). 9132–9148. 20 indexed citations
4.
Kapor, Sunčica, Slavko Mojsilović, Branka Filipović, et al.. (2023). Increase in Frequency of Myeloid-Derived Suppressor Cells in the Bone Marrow of Myeloproliferative Neoplasm: Potential Implications in Myelofibrosis. Advances in experimental medicine and biology. 1408. 273–290. 4 indexed citations
5.
Kapor, Sunčica, et al.. (2022). Inhibition of proinflammatory signaling impairs fibrosis of bone marrow mesenchymal stromal cells in myeloproliferative neoplasms. Experimental & Molecular Medicine. 54(3). 273–284. 7 indexed citations
6.
Mojsilović, Slavko, et al.. (2021). Paclitaxel inhibits transforming growth factor-β-increased urokinase-type plasminogen activator expression through p38 MAPK and RAW 264.7 macrophage migration.. PubMed. 25(2). 1257–1265.
7.
Filipović, Branka, et al.. (2021). The Role of Psychotherapy in the Treatment of Patients with Non– alcoholic Fatty Liver Disease and Obstructive Sleep Apnea. Journal of Gastrointestinal and Liver Diseases. 30(4). 477–484. 2 indexed citations
8.
Kapor, Sunčica, Vladan P. Čokić, & Juan F. Santibáñez. (2021). Mechanisms of Hydroxyurea‐Induced Cellular Senescence: An Oxidative Stress Connection?. Oxidative Medicine and Cellular Longevity. 2021(1). 7753857–7753857. 23 indexed citations
9.
Mojsilović, Slavko, et al.. (2021). Transforming growth factor‐beta1 and myeloid‐derived suppressor cells: A cancerous partnership. Developmental Dynamics. 251(1). 85–104. 22 indexed citations
10.
Filipović, Branka, Snežana Lukić, Dragana Mijač, et al.. (2021). The New Therapeutic Approaches in the Treatment of Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences. 22(24). 13219–13219. 29 indexed citations
13.
Ajtić, Olivera Mitrović, Sunčica Kapor, Bojana Beleslin‐Čokić, et al.. (2019). IL6 inhibition of inflammatory S100A8/9 proteins is NF‐κB mediated in essential thrombocythemia. Cell Biochemistry and Function. 38(4). 362–372. 7 indexed citations
14.
Marković, Dragana, Andrija Bogdanović, Olivera Mitrović Ajtić, et al.. (2019). Oxidative and nitrosative stress in myeloproliferative neoplasms: the impact on the AKT / mTOR signaling pathway.. PubMed. 23(5). 1481–1491. 11 indexed citations
15.
Millán, Carola, et al.. (2018). Mesenchymal Stem Cells and Calcium Phosphate Bioceramics: Implications in Periodontal Bone Regeneration. Advances in experimental medicine and biology. 1107. 91–112. 13 indexed citations
16.
Mojsilović, Slavko, et al.. (2018). Estramustine Phosphate Inhibits TGF-β-Induced Mouse Macrophage Migration and Urokinase-Type Plasminogen Activator Production. Analytical Cellular Pathology. 2018. 1–10. 2 indexed citations
17.
Santibáñez, Juan F. & Sunčica Kapor. (2018). Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation. Recent Patents on Anti-Cancer Drug Discovery. 13(2). 133–144. 7 indexed citations
18.
Maksimović, Nataša, et al.. (2018). Psychosomatic factors of atopic dermatitis exacerbation. International Journal of Dermatology. 57(9). 1080–1084. 6 indexed citations
19.
Ajtić, Olivera Mitrović, Bojana Beleslin‐Čokić, Sunčica Kapor, et al.. (2018). IL‐6 stimulation of DNA replication is JAK1/2 mediated in cross‐talk with hyperactivated ERK1/2 signaling. Cell Biology International. 43(2). 192–206. 5 indexed citations
20.
Santibáñez, Juan F. & Sunčica Kapor. (2017). Transforming Growth Factor-Beta1 and Myeloid-Derived Suppressor Cells Interplay in Cancer. 6(1). 1–14. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026